In a report released on January 27, Naz Rahman from Maxim Group reiterated a Buy rating on Silexion Therapeutics (SLXN – Research Report), with ...

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

Market is Segmented by Type (Recombinant, Native), by Application (Hematopoietic Stem Cell Research and Treatment, Cancer Research and Treatment). The Global Stem Cell Factor (SCF) Market was valued ...

CPAP therapy, the traditional standard for obstructive sleep apnea (OSA), is universally despised by patients, resulting in abysmally low compliance rates. Recent studies show it also fails to ...

Three nano-cap healthcare stocks drew massive attention from retail investors on Stocktwits Tuesday, though not all for ...

Silexion Therapeutics Corp. (NASDAQ:SLXN) released new preclinical data for SIL-204, its next-generation siRNA therapeutic ...

CAYMAN ISLANDS - Silexion Therapeutics Corp. (NASDAQ: SLXN), a biotech firm focusing on RNA interference (RNAi) treatments, ...

New preclinical findings provide validation for Silexion’s new systemic administration approach for SIL-204, demonstrating ...

The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.35 A.M. ET).In the Green Tectonic Therapeutic, Inc. (TECX) is up over ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.